argus

Mankind Pharma Limited

NSE: MANKINDINE634S0102897,467 Cr

Timeline

Time (IST)TypeMEventSrc
31 Aug, 08:06 pmother1Mankind Pharma Limited provides general updates to the Exchange without disclosing any specific financial, operational, or strategic events.nse
31 Aug, 08:04 pmMankind Pharma Ltd - 543904 - Update On Disinvestmentbse
30 Aug, 10:29 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Change in Managementbse
30 Aug, 10:27 pmMankind Pharma Limited has informed the Exchange regarding Cessation of Mr Bharat Anand as Non- Executive Independent Director of the company w.e.f. August 30, 2026.nse
26 Aug, 04:44 pmPlease find attached outcome of Board Meeting held today, according consent of the Board of Directors of the Company for the integration of Bharat Serums and Vaccines Limtied, a wholly owned material subsidiary, into the Company by way of voluntary liquidation.nse
26 Aug, 04:43 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Restructuringbse
26 Aug, 04:39 pmPlease find attached outcome of Board Meeting held today, according consent of the Board of Directors of the Company for the integration of Bharat Serums and Vaccines Limtied, a wholly owned material subsidiary, into the Company by way of voluntary liquidation.nse
26 Aug, 04:38 pmMankind Pharma Ltd - 543904 - Board Meeting Outcome for Dated August 26, 2026bse
22 Aug, 02:01 pmMankind Pharma Limited has informed the Exchange about General Updatesnse
22 Aug, 01:58 pmMankind Pharma Ltd - 543904 - Intimation Regarding ESG Ratingbse
20 Aug, 01:37 pmMankind Pharma Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Mankind Pharma Enters into Exclusive In-Licensing Agreement for Insulin Degludec and Insulin Degludec + Aspart Combination for India".nse
20 Aug, 01:35 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
17 Aug, 11:09 pmCompletion of Realignment of Security Cover in respect of Non-ConvertibleDebentures and Consequent Release of Pledged Shares of Bharat Serums andVaccines Limitednse
13 Aug, 09:31 pmMankind Pharma Limited has informed the Exchange about Acquisitionnse
13 Aug, 09:28 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Updates on Acquisitionbse
10 Aug, 04:22 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Change in Managementbse
10 Aug, 04:21 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Change in Managementbse
10 Aug, 04:16 pmMankind Pharma Limited has informed the Exchange regarding Appointment of Mr Anish Vanraj Bafna as Non- Executive Independent Director of the company w.e.f. August 10, 2026.nse
10 Aug, 04:13 pmMankind Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on August 10, 2026.nse
10 Aug, 04:10 pmMankind Pharma Ltd - 543904 - Board Meeting Outcome for For Appointment Of An Additional Director Designated As Non-Executive Independent Directorbse
04 Aug, 01:25 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
04 Aug, 01:13 pmMankind Pharma Limited has informed the Exchange about Transcriptnse
30 Jul, 08:30 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
30 Jul, 08:28 pmMankind Pharma Limited has informed the Exchange about Link of Recordingnse
30 Jul, 04:01 pmPlease find attached certificate under Regulation 54 of the SEBI (LODR) Regulations, 2015nse
30 Jul, 03:58 pmMankind Pharma Ltd - 543904 - Compliances-Reg. 54 - Asset Cover detailsbse
30 Jul, 03:54 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
30 Jul, 03:53 pmMankind Pharma Limited has informed the Exchange regarding a press release dated July 30, 2026, titled "Press Release on Financial Results for Q1FY27".nse
30 Jul, 03:48 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
30 Jul, 03:46 pmMankind Pharma Limited has informed the Exchange about Investor Presentationnse
30 Jul, 03:41 pmMankind Pharma Ltd - 543904 - Approval For Issuance Of Corporate Guaranteebse
30 Jul, 03:31 pmMankind Pharma Limited has informed the Exchange about Giving guarantees/indemnity/ becoming a surety for third partynse
30 Jul, 03:28 pmMankind Pharma Ltd - 543904 - Un-Audited Financial Results Of The Company For The Quarter Ended On June 30, 2026bse
30 Jul, 03:22 pmMankind Pharma Ltd - 543904 - Board Meeting Outcome for Outcome Of Board Meetingbse
30 Jul, 03:21 pmMankind Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
27 Jul, 06:30 pmFinal update on Stake Sale of Broadway Hospitality Services Private Limitednse
16 Jul, 04:32 pmMankind Pharma Ltd - 543904 - Board Meeting Intimation for Approval Of Financial Resultsbse
11 Jul, 01:31 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestmentbse
11 Jul, 01:28 pmMankind Pharma Limited has informed the Exchange about Acquisitionnse
11 Jul, 01:27 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Acquisitionbse
11 Jul, 01:26 pmMankind Pharma Limited has informed the Exchange about Diversification/Disinvestmentnse
11 Jul, 01:24 pmMankind Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 11, 2026.nse
09 Jul, 04:55 pmMankind Pharma Ltd - 543904 - Regulation 53 (1) Annual Report.bse
09 Jul, 04:46 pmMankind Pharma Ltd - 543904 - Reg. 34 (1) Annual Report.bse
30 Jun, 11:54 amMankind Pharma Limited has informed the Exchange about General Updatesnse
10 Jun, 03:56 pmprocedural0Ramesh Juneja submitted a copy of a SEBI Takeover Regulations (Regulation 31(4)) disclosure to the exchange.nse
08 Jun, 10:34 pmMankind Pharma Limited has informed the Exchange regarding Cessation of Mr Prateek Dubey as SMP of the company w.e.f. Jun 08, 2026.nse
08 Jun, 10:31 pmMankind Pharma Limited has informed the Exchange regarding Appointment of Mr Nilesh Kulkarni as SMP of the company w.e.f. Jun 08, 2026.nse
08 Jun, 10:22 pmMankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Change in Managementbse
08 Jun, 06:13 pmMankind Pharma Limited has informed the Exchange regarding allotment of 86778 securities pursuant to ESOP/ESPS at its meeting held on Jun 08, 2026nse